What to expect after tricuspid valve replacement? Long-term results

Işcan, Zafer; Vural, Kerem M.; Bahar, İlknur; Mavioğlu, Levent; Sarıtaş, Ahmet

doi:10.1016/j.ejcts.2007.05.003

Cited by 72 publications

(55 citation statements)

References 8 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Results showed an in-hospital mortality of 26% and a 10-year event free survival of 31%. Rheumatic etiology and elevated pulmonary artery pressures were risk factors for poor outcome (13). These results are not dissimilar from those reported by other groups.…”

Section: Clinical Resultssupporting

confidence: 68%

Surgical management of tricuspid stenosis

Cevasco¹,

Shekar²

2017

Ann. Cardiothorac. Surg.

View full text Add to dashboard Cite

Tricuspid valve stenosis (TS) is rare, affecting less than 1% of patients in developed nations and approximately 3% of patients worldwide. Detection requires careful evaluation, as it is almost always associated with left-sided valve lesions that may obscure its significance. Primary TS is most frequently caused by rheumatic valvulitis. Other causes include carcinoid, radiation therapy, infective endocarditis, trauma from endomyocardial biopsy or pacemaker placement, or congenital abnormalities. Surgical management of TS is not commonly addressed in standard cardiac texts but is an important topic for the practicing surgeon. This paper will elucidate the anatomy, pathophysiology, and surgical management of TS.

show abstract

Section: Clinical Resultssupporting

confidence: 68%

Surgical management of tricuspid stenosis

Cevasco¹,

Shekar²

2017

Ann. Cardiothorac. Surg.

View full text Add to dashboard Cite

show abstract

“…355 Recent data reported equivalent 10-year event-free survival was 31% for patients undergoing tricuspid valve replacement, with no statistically significant difference between mechanical or bioprosthetic valves. 383 An approach that integrates patient preference in the absence of clear contraindications is likely to result in improved outcomes.…”

Section: Isolated Pulmonary Valve Stenosismentioning

confidence: 99%

Congenital Heart Disease in the Older Adult

Bhatt¹,

Foster²,

Kuehl³

et al. 2015

Circulation

203

View full text Add to dashboard Cite

“…Moreover, they are at increased risk for both atrial and ventricular arrhythmias [12]. As the morbidity and mortality risk associated with surgical TV replacement is often high [5], the excellent short-and intermediate-term outcomes of trans-catheter valve replacement make it a viable alternative.…”

Section: Discussionmentioning

confidence: 99%

“…In patients with congenital forms of TR, surgical replacement may be necessary at a young age; longer-lasting mechanical valves would require placing young patients on anticoagulants, and yet bioprosthetic valves commonly require replacement within 10-15 years [3,4]. Use of biological valves early in life most certainly predicts multiple reoperations as they begin to fail, and repeat surgery is associated with increased morbidity and mortality [5].…”

Section: Introductionmentioning

confidence: 99%